Spots Global Cancer Trial Database for Positron Emission Tomography - Computed Tomography (PET-CT) Cetuximab Project
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Positron Emission Tomography - Computed Tomography (PET-CT) Cetuximab Project
Official Title: Imaging for Early Response Prediction to EGF-receptor Blocking Monoclonal Antibodies in Combination Therapy for Colorectal Cancer
Study ID: NCT00828620
Conditions
Interventions
Study Description
Brief Summary: Molecular imaging with positron emission tomography (PET) using \[18F\] fluorodeoxyglucose (FDG) has been suggested as an early, sensitive marker of tumour response to anticancer drugs by monitoring the changes in glucose metabolism in tumours. Recently, FDG-PET has shown to be highly sensitive in detecting early response in other tumours. In this study, the investigators will prospectively investigate the role of early FDG-PET (at day 7 and week 6) in outcome prediction.
Detailed Description:
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
ZNA Middelheim, Antwerpen, , Belgium
AZ Groeninge, Kortrijk, , Belgium
UZLeuven, Leuven, , Belgium
H Hart Roeselare Campus menen, Menen, , Belgium
Stedelijk Ziekenhuis Roeselare, Roeselare, , Belgium
Sint Augustinus Ziekenhuis, Wilrijk, , Belgium
Contact Details
Name: Eric Van Cutsem, Prof.Dr
Affiliation: UZ Leuven
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
